Grossi, Carlota M.Richardson, KathrynFox, ChrisMaidment, IanSteel, NicholasLoke, Yoon K.Arthur, AntonyMyint, Phyo KyawCampbell, NollBoustani, MalazRobinson, LouiseBrayne, CarolMatthews, Fiona E.Savva, George M.2019-10-232019-10-232019-10-21Grossi, C M, Richardson, K, Fox, C, Maidment, I, Steel, N, Loke, Y K, Arthur, A, Myint, P K, Campbell, N, Boustani, M, Robinson, L, Brayne, C, Matthews, F E & Savva, G M 2019, 'Anticholinergic and benzodiazepine medication use and risk of incident dementia : a UK cohort study', BMC Geriatrics, vol. 19, 276. https://doi.org/10.1186/s12877-019-1280-21471-2318ORCID: /0000-0003-3852-6158/work/163198482https://hdl.handle.net/2164/13152Availability of data and materials Data can be shared through application. For further information please refer to the application forms on the website http://www.cfas.ac.uk/cfas-i/data/#cfasi-data-request. Acknowledgments We would like to thank the MRC CFAS study group for data collection and management. We are also grateful to all respondents, their families and their primary care teams for their participation in the MRC CFAS. We would like to thank Mr. Barry Plumpton, Mrs. Ann McLauchlan, Mrs. Barbara di Vita, and Mrs. Gloria Swan for providing valuable assistance in interpretation and oversight as Alzheimer’s Society Research Network Volunteers. Funding This work was supported by the UK Alzheimer’s Society [AS-PG-2013-017]. The funders had no role in the design of the study or the interpretation of the findings.10724794engAlzheimer diseaseCognitionDementiaCohort studyBenzodiazepinesCholinergic antagonistsDRUGSDISEASEOLDERCOGNITIVE IMPAIRMENTPREVALENCER MedicineGeriatrics and GerontologyAlzheimers Research UKAS-PG-2013-017Supplementary DataRJournal article10.1186/s12877-019-1280-2http://www.scopus.com/inward/record.url?scp=85073708327&partnerID=8YFLogxK19